90%Confidence
0Views
FDASource
2026-04-15Date
Summary
Additional sterility failures for K.C. Pharmaceuticals' lubricating eye drops expand the scope of quality control problems. Harris Teeter and other retailers face potential product removal and consumer safety concerns.
Actionable: Check supply chains for affected eye drop products and communicate with distributors about quality assurance.
AI Confidence: 90%
Data Points
firmK.C. Pharmaceuticals, Inc
classificationClass II
statusOngoing
distributionNationwide in the US
productUltra Lubricating Eye Drops (polyethylene 400 0.4%, propylene glycol 0.3%), Sterile, 0.5 FL OZ (15mL) bottles; a) LEADER, DISTRIBUTED BY CARDINAL HEAL
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now